학술논문
Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled trial
Document Type
Conference Paper
Author
Source
In: Diabetes Care . (Diabetes Care, 1 November 2016, 39(11):2042-2050)
Subject
Language
English
ISSN
19355548
01495992
01495992